RAPTOR PHARMACEUTICALS

raptor-pharmaceuticals-logo

Raptor Pharmaceuticals Corp. operates as a development stage biotechnology company in the United States. The company engages in the discovery, research, and preclinical development of drug candidates and drug-targeting platforms for the treatment of various brain disorders and neurodegenerative diseases, genetic disorders, and cancer through the proprietary use of receptor-associated proteins and mesoderm development proteins. Its clinical-stage products include DR Cysteamine, which is in Phase ... IIb clinical trail for the treatment of nephropathic cystinosis or cystinosis; and in Phase IIa clinical trail for the treatment of non-alcoholic steatohepatitis. The company also develops Convivia, a Phase IIa clinical trail product for the treatment of aldehyde dehydrogenase or ALDH2 deficiency; DR Cysteamine, which is in Phase II clinical trail for the treatment of Huntington's Disease; and Tezampanel and NGX 426 that is in Phase II clinical trail for the treatment of migraine, acute pain, and chronic pain. In addition, its preclinical development products comprise HepTide for the treatment of Hepatocellular Carcinoma and Hepatitis C; WntTide for the treatment of breast cancer; and NeuroTrans for the treatment of neurodegenerative diseases. The company has collaboration agreements with the University of California, San Diego for a clinical study of DR Cysteamine in juvenile patients with Non-Alcoholic Steatohepatitis and to study DR Cysteamine in patients with cystinosis. Raptor Pharmaceuticals Corp was founded in 2005 and is based in Novato, California.

#SimilarOrganizations #People #Financial #Website #More

RAPTOR PHARMACEUTICALS

Industry:
Biopharma Biotechnology Genetics Therapeutics

Founded:
2002-04-01

Address:
Novato, California, United States

Country:
United States

Website Url:
http://www.raptorpharma.com

Total Employee:
51+

Status:
Active

Contact:
4153828002

Email Addresses:
[email protected]

Total Funding:
172.89 M USD

Technology used in webpage:
SPF Google Tag Manager Domain Not Resolving Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS JQuery CDN Apache 2.4 Sectigo SSL Sectigo Domain SSL


Similar Organizations

adamis-pharmaceuticals-logo

Adamis Pharmaceuticals

Adamis Pharmaceuticals is a biopharmaceutical company developing therapeutics for respiratory diseases and cancer.

chiasma-logo

Chiasma

Chiasma is a biopharmaceutical company developing oral drugs for the treatment of orphan diseases.

civitas-therapeutics-logo

Civitas Therapeutics

Civitas Therapeutics is a biopharmaceutical company that focuses on developing pulmonary delivery therapies.

edgewise-therapeutics-logo

Edgewise Therapeutics

Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.


Current Advisors List

suzanne-l-bruhn_image

Suzanne L. Bruhn Board Member @ Raptor Pharmaceuticals
Board_member

Current Employees Featured

not_available_image

Kim R. Tsuchimoto
Kim R. Tsuchimoto CFO @ Raptor Pharmaceuticals
CFO

todd-zankel_image

Todd Zankel
Todd Zankel Co-Founder @ Raptor Pharmaceuticals
Co-Founder

Founder


christopher-m-starr_image

Christopher M. Starr

todd-zankel_image

Todd Zankel

Stock Details


Company's stock symbol is NASDAQ:RPTP

Acquisitions List

Date Company Article Price
2009-09-29 TorreyPines Therapeutics TorreyPines Therapeutics acquired by Raptor Pharmaceuticals N/A

Investors List

healthcare-royalty-partners_image

HealthCare Royalty Partners

HealthCare Royalty Partners investment in Post-IPO Debt - Raptor Pharmaceuticals

heights-capital-management_image

Heights Capital Management

Heights Capital Management investment in Post-IPO Equity - Raptor Pharmaceuticals

iroquois-capital_image

Iroquois Capital

Iroquois Capital investment in Post-IPO Equity - Raptor Pharmaceuticals

deerfield-management_image

Deerfield Capital Management

Deerfield Capital Management investment in Post-IPO Equity - Raptor Pharmaceuticals

dafna-capital-management_image

Dafna Capital Management

Dafna Capital Management investment in Post-IPO Equity - Raptor Pharmaceuticals

lincoln-park-capital-fund_image

Lincoln Park Capital Fund

Lincoln Park Capital Fund investment in Post-IPO Equity - Raptor Pharmaceuticals

Official Site Inspections

http://www.raptorpharma.com

  • Host name: 206.176.233.40
  • IP address: 206.176.233.40
  • Location: Petaluma United States
  • Latitude: 38.2478
  • Longitude: -122.6192
  • Metro Code: 807
  • Timezone: America/Los_Angeles
  • Postal: 94954

Loading ...

More informations about "Raptor Pharmaceuticals" on Search Engine